Tumeurs des glandes salivaires. État des lieux en 2009

2005, Pathology and genetics of head and neck tumours 2008, AFIP Atlas of tumor pathology AJCC cancer staging manual. 6th ed. New York, NY: Springer; 2002. Edwards, 2003, C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 95, 586, 10.1067/moe.2003.31 Schroeder, 2008, Parotid cancer: Impact of changes from the 1997 to the 2002 American Joint Committee on Cancer classification on outcome prediction, Cancer, 113, 758, 10.1002/cncr.23626 Behboudi, 2006, Molecular classification of mucoepidermoid carcinomas — prognostic significance of the MECT1–MAML2 fusion oncogene, Genes Chromosomes Cancer, 45, 470, 10.1002/gcc.20306 Seethala, 2009, An update on grading of salivary gland carcinomas, Head Neck Pathol, 69, 69, 10.1007/s12105-009-0102-9 Cheuk, 2007, Advances in salivary gland pathology, Histopathology, 51, 1, 10.1111/j.1365-2559.2007.02719.x Luukkaa, 2006, Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases, Acta Oncol, 45, 669, 10.1080/02841860500543208 Kas, 1997, Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations, Nat Genet, 15, 170, 10.1038/ng0297-170 Voz, 2000, PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II, Cancer Res, 60, 106 Voz, 1998, The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter, Oncogene, 16, 1409, 10.1038/sj.onc.1201660 Astrom, 1999, Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene, Cancer Res, 59, 918 Asp, 2006, CHCHD7–PLAG1 and TCEA1–PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas, Genes Chromosomes Cancer, 45, 820, 10.1002/gcc.20346 El-Naggar, 2000, Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model?, Genes Chromosomes Cancer, 27, 162, 10.1002/(SICI)1098-2264(200002)27:2<162::AID-GCC7>3.0.CO;2-9 Rao, 1998, Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland, Cancer Genet Cytogenet, 105, 160, 10.1016/S0165-4608(98)00013-2 Roijer, 2002, Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma, Am J Pathol, 160, 433, 10.1016/S0002-9440(10)64862-6 Di Palma, 2005, Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry, Histopathology, 46, 144, 10.1111/j.1365-2559.2005.02058.x Tonon, 2003, t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway, Nat Genet, 33, 208, 10.1038/ng1083 Goode, 1998, Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria, Cancer, 82, 1217, 10.1002/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C Brandwein, 1996, Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 81, 655, 10.1016/S1079-2104(96)80071-0 Skalova, 1994, Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections, Hum Pathol, 25, 929, 10.1016/0046-8177(94)90014-0 Lennerz, 2009, Mucoepidermoid carcinoma of the Cervix Another Tumor With the t(11;19)-associated CRTC1-MAML2Gene Fusion, Am J Surg Pathol, 33, 835, 10.1097/PAS.0b013e318190cf5b Serra, 2007, t(11;19)(q21;p12∼p13.11) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma, J Pediatr Surg, 42, 23, 10.1016/j.jpedsurg.2007.04.031 Bullerdiek, 1988, Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland, Cancer Genet Cytogenet, 35, 129, 10.1016/0165-4608(88)90131-8 Martins, 2004, A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands, J Mol Diagn, 6, 205, 10.1016/S1525-1578(10)60511-9 Brannon, 2003, Oncocytic mucoepidermoid carcinoma of parotid gland origin, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 96, 727, 10.1016/S1079-2104(03)00377-9 Urano, 2002, Sclerosing mucoepidermoid carcinoma with eosinophilia of the salivary glands, Pathol Res Pract, 198, 305, 10.1078/0344-0338-00259 Skalova, 1994, Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections, J Pathol, 173, 13, 10.1002/path.1711730104 Frierson, 2002, Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma, Am J Pathol, 161, 1315, 10.1016/S0002-9440(10)64408-2 Stallmach, 2002, Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma, Virchows Arch, 440, 77, 10.1007/s004280100523 Norberg-Spaak, 2000, Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome, Head Neck, 22, 489, 10.1002/1097-0347(200008)22:5<489::AID-HED8>3.0.CO;2-X Nordgård, 1997, Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections, Laryngoscope, 107, 531, 10.1097/00005537-199704000-00019 Hotte, 2005, Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study, J Clin Oncol, 23, 585, 10.1200/JCO.2005.06.125 Smith, 1996, Sclerosing polycystic adenosis of major salivary glands. A clinicopathologic analysis of nine cases, Am J Surg Pathol, 20, 161, 10.1097/00000478-199602000-00004 Gnepp, 2003, Sclerosing polycystic adenosis of the salivary gland: a lesion that may be associated with dysplasia and carcinoma in situ, Adv Anat Pathol, 10, 218, 10.1097/00125480-200307000-00005 Gnepp, 2006, Sclerosing polycystic adenosis of the salivary gland: a report of 16 cases, Am J Surg Pathol, 30, 154, 10.1097/01.pas.0000186394.64840.1d Ma, 2002, Lymphadenoma: a report of three cases of an uncommon salivary gland neoplasm, Histopathology, 41, 342, 10.1046/j.1365-2559.2002.01528.x Jang, 2009, Sialolipoma: case report and review of 27 cases, Oral Maxillofac Surg, 13, 109, 10.1007/s10006-009-0153-9 Seethala, 2009, New variants of epithelial-myoepithelial carcinoma: oncocytic-sebaceous and apocrine, Arch Pathol Lab Med, 133, 950, 10.5858/133.6.950 Michal, 1999, Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue, Histopathology, 35, 495, 10.1046/j.1365-2559.1999.00792.x Uro-Coste, 2007, Particularité des tumeurs des glandes salivaires accessoires, Ann Pathol, 27, 1S76, 10.1016/S0242-6498(07)92873-4 Ghannoum, 2004, Signet-ring cell (mucin-producing) adenocarcinomas of minor salivary glands, Am J Surg Pathol, 28, 89, 10.1097/00000478-200401000-00010 Ide, 2009, Mucinous adenocarcinoma of minor salivary glands: a high-grade malignancy prone to lymph node metastasis, Virchows Arch, 454, 55, 10.1007/s00428-008-0699-1 Ettl, 2008, Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas, Histopathology, 53, 567, 10.1111/j.1365-2559.2008.03159.x Vidal, 2009, Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib, Head Neck, 10.1002/hed.21052 Volker, 2009, Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses, Diagn Pathol, 4, 18, 10.1186/1746-1596-4-18 Maruya, 2009, Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications, BMC Cancer, 9, 72, 10.1186/1471-2407-9-72 Miyabe, 2009, Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases, J Oral Maxillofac Surg, 67, 1432, 10.1016/j.joms.2009.03.021 Nagler, 2009, The expression and prognostic significance of Cks1 in salivary cancer, Cancer Invest, 27, 512, 10.1080/07357900802239116 Nikitakis, 2009, The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107, 826, 10.1016/j.tripleo.2008.12.054 Schwarz, 2008, Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors, Oral Oncol, 44, 563, 10.1016/j.oraloncology.2007.07.004 Vered, 2009, Is maspin immunolocalization a tool to differentiate central low-grade mucoepidermoid carcinoma from glandular odontogenic cyst?, Acta Histochem Zhang, 2009, Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland, Int J Cancer, 124, 2855, 10.1002/ijc.24298 Skalova, 2006, Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker, Am J Surg Pathol, 30, 939, 10.1097/00000478-200608000-00002